Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Suramin With Sequential Doxorubicin in Patients With Advanced Solid Tumors

NCT00003038 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00003038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Suramin With Sequential Doxorubicin in Patients With Advanced Solid Tumors
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
October 31, 1997
Completion date
January 31, 2003
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenocortical carcinoma, breast cancer, colorectal cancer, prostate cancer, unspecified adult solid tumor, protocol specific